Enhanced differentiation of human amniotic fluid-derived stem cells into insulin-producing cellsin vitro
Author:
Affiliation:
1. Department of Central Laboratory; China-Japan Union Hospital of Jilin University; Changchun China
2. College of Pharmacy; Jilin University; Changchun China
3. The Second Affiliated Hospital of Jilin University; Changchun China
Funder
National Natural Science Foundation of China
Publisher
Wiley
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdi.12544/fullpdf
Reference42 articles.
1. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol;Tsai;Hum Reprod,2004
2. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?;Prusa;Hum Reprod,2003
3. Isolation of amniotic stem cell lines with potential for therapy;De Coppi;Nat Biotechnol,2007
4. Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow;Tsai;Stem Cells,2007
5. Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application;Sessarego;Haematologica,2008
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Diabetes current and future translatable therapies;Endocrine;2024-07-06
2. The efficiency of stem cell differentiation into functional beta cells for treating insulin-requiring diabetes: Recent advances and current challenges;Endocrine;2024-05-10
3. Production of alginate macrocapsule device for long-term normoglycaemia in the treatment of type 1 diabetes mellitus with pancreatic cell sheet engineering;Biomedical Materials;2024-01-19
4. Perinatal Stem Cell Therapy to Treat Type 1 Diabetes Mellitus: A Never-Say-Die Story of Differentiation and Immunomodulation;International Journal of Molecular Sciences;2022-11-23
5. Tissue engineering approaches and generation of insulin-producing cells to treat type 1 diabetes;Journal of Drug Targeting;2022-08-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3